Article info

Download PDFPDF

Original article
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial

Authors

  1. Correspondence to Dr Gene Wallenstein; Gene.wallenstein{at}pfizer.com
View Full Text

Citation

Strand V, Lee EB, Fleischmann R, et al
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial

Publication history

  • Received May 12, 2016
  • Revision received July 28, 2016
  • Accepted August 5, 2016
  • First published September 28, 2016.
Online issue publication 
September 28, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.